|
1.
|
Pauli A, Rinn JL and Schier AF: Non-coding
RNAs as regulators of embryogenesis. Nat Rev Genet. 12:136–149.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5845. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
O’Connell MR, Rao DS, Chaudhuri AA and
Baltimore D: Physiological and pathological roles for microRNAs in
the immune system. Nat Rev Immunol. 10:111–122. 2010.PubMed/NCBI
|
|
4.
|
Garofalo M and Croce CM: microRNAs: master
regulators as potential therapeutics in cancer. Annu Rev Pharmacol
Toxicol. 51:25–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Griffiths-Jones S, Saini HK, van Dongen S
and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids
Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Lagos-Quintana M, Rauhut R, Meyer J,
Borkhardt A and Tuschl T: New microRNAs from mouse and human. RNA.
9:175–179. 2003. View Article : Google Scholar
|
|
7.
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Vaz C, Ahmad HM, Sharma P, Gupta R, Kumar
L, Kulshreshtha R and Bhattacharya A: Analysis of microRNA
transcriptome by deep sequencing of small RNA libraries of
peripheral blood. BMC Genomics. 11:2882010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Huang Y, Zou Q, Wang SP, Tang SM, Zhang GZ
and Shen XJ: The discovery approaches and detection methods of
microRNAs. Mol Biol Rep. 38:4125–4135. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Ambros V, Bartel B, Bartel DP, et al: A
uniform system for microRNA annotation. RNA. 9:277–279. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Berezikov E, Cuppen E and Plasterk RHA:
Approaches to microRNA discovery. Nat Genet. 38:S2–S7. 2006.
View Article : Google Scholar
|
|
12.
|
Takane K, Fujishima K, Watanabe Y, Sato A,
Saito N, Tomita M and Kanai A: Computational prediction and
experimental validation of evolutionarily conserved microRNA target
genes in bilaterian animals. World J Gastroenterol. 17:1910–1914.
2011.PubMed/NCBI
|
|
13.
|
McKillop IH, Moran DM, Jin X and Koniaris
LG: Molecular pathogenesis of hepatocellular carcinoma. J Surg Res.
136:125–135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Barlati S, Zoppi N, Copeta A, Tavian D, De
Petro G and Colombi M: Quantitative in situ hybridization for the
evaluation of gene expression in asynchronous and synchronized cell
cultures and in tissue sections. Histol Histopathol. 14:1231–1240.
1999.PubMed/NCBI
|
|
15.
|
Salvi A, Sabelli C, Moncini S, Venturin M,
Arici B, Riva P, Portolani N, Giulini SM, De Petro G and Barlati S:
MicroRNA-23b mediates urokinase and c-met downmodulation and a
decreased migration of human hepatocellular carcinoma cells. FEBS
J. 276:2966–2982. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, et al: A polycistronic
microRNA cluster, miR-17-92, is overexpressed in human lung cancers
and enhances cell proliferation. Cancer Res. 65:9628–9632. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Inomata M, Tagawa H, Guo YM, Kameoka Y,
Takahashi N and Sawada K: MicroRNA-17-92 down-regulates expression
of distinct targets in different B-cell lymphoma subtypes. Blood.
113:396–402. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, et al: E2F1-regulated
microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis
in gastric cancer. Cancer Cell. 13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Si ML, Zhu S, Wu HS, Lu Z, Wu F and Mo Y:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Gaur AB, Holbeck SL, Colburn NH and Israel
MA: Downregulation of Pdcd4 by miR-21 facilitates glioblastoma
proliferation in vivo. Neurooncology. 13:580–590. 2011.PubMed/NCBI
|
|
23.
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, et al: RAS is regulated by the
let-7 microRNA family. Cell. 120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sampson VB, Rong NH, Han J, Yang Q, Aris
V, Soteropoulos P, Petrelli NJ, et al: MicroRNA let-7a
down-regulates MYC and reverts MYC-induced growth in Burkitt
lymphoma cells. Cancer Res. 67:9762–9770. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Osada H and Takahashi T: let-7 and
miR-17-92: small-sized major players in lung cancer development.
Cancer Sci. 102:9–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: miR-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Garzon R, Heaphy CE, Havelange V, Fabbri
M, Volinia S, Tsao T, Zanesi N, et al: MicroRNA 29b functions in
acute myeloid leukemia. Blood. 114:5331–5341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Bai S, Nasser MW, Wang B, Hsu SH, Datta J,
Kutay H, Yadav A, et al: MicroRNA-122 inhibits tumorigenic
properties of hepato-cellular carcinoma cells and sensitizes these
cells to sorafenib. J Biol Chem. 284:32015–32027. 2009. View Article : Google Scholar
|
|
29.
|
Fu H, Tie Y, Xu C, Zhang Z, Zhu J, Shi Y,
Jiang H, et al: Identification of human fetal liver miRNAs by a
novel method. FEBS Lett. 579:3849–3854. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mizuguchi Y, Mishima T, Yokomuro S, Arima
Y, Kawahigashi Y, Shigehara K, Kanda T, et al: Sequencing and
bioinformatics-based analyses of the microRNA transcriptome in
hepatitis B-related hepatocellular carcinoma. PLoS One.
6:e153042011. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Wang X, Tang S, Le SY, Lu R, Rader JS,
Meyers C and Zheng ZM: Aberrant expression of oncogenic and
tumor-suppressive microRNAs in cervical cancer is required for
cancer cell growth. PLoS One. 3:e25572008. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Kwak PB, Iwasaki S and Tomari Y: The
microRNA pathway and cancer. Cancer Sci. 101:2309–2315. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Chhabra R, Adlakha YK, Hariharan M, Scaria
V and Saini N: Upregulation of miR-23a-27a-24-2 cluster induces
caspase-dependent and -independent apoptosis in human embryonic
kidney cells. PLoS One. 4:e58482009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L
and Wang Z: miR-27a modulates MDR1/P-glycoprotein expression by
targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol.
119:125–130. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Lal A, Navarro F, Maher CA, Maliszewski
LE, Yan N, O’Day E, Chowdhury D, et al: miR-24 inhibits cell
proliferation by targeting E2F2, MYC, and other cell-cycle genes
via binding to ‘seedless’ 3′UTR microRNA recognition elements. Mol
Cell. 35:610–625. 2009.PubMed/NCBI
|
|
36.
|
Lal A, Kim HH, Abdelmohsen K, Kuwano Y,
Pullmann R Jr, Srikantan S, Subrahmanyam R, et al: p16(INK4a)
translation suppressed by miR-24. PLoS One. 3:e18642008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Qin W, Shi Y, Zhao B, Yao C, Jin L, Ma J
and Jin Y: miR-24 regulates apoptosis by targeting the open reading
frame (ORF) region of FAF1 in cancer cells. PLoS One. 5:e94292010.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Jiang J, Gusev Y, Aderca I, Mettler TA,
Nagorney DM, Brackett DJ, Roberts LR and Schmittgen TD: Association
of microRNA expression in hepatocellular carcinomas with hepatitis
infection, cirrhosis, and patient survival. Clin Cancer Res.
14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
